Multicenter Phase II/III Clinical Study of Lipoplatin plus Gemcitabine as First-Line Treatment in Inoperable, Locally Advanced or Metastatic Pancreatic Cancer.
Withdrawn prior to enrolment
Phase of Trial: Phase II/III
Latest Information Update: 25 Nov 2016
At a glance
- Drugs Cisplatin; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 24 Nov 2016 Status changed from recruiting to withdrawn prior to enrolment.
- 07 Jun 2011 New trial record